SERPALAN Drug Patent Profile
✉ Email this page to a colleague
When do Serpalan patents expire, and when can generic versions of Serpalan launch?
Serpalan is a drug marketed by Lannett and is included in one NDA.
The generic ingredient in SERPALAN is reserpine. There are nineteen drug master file entries for this compound. Additional details are available on the reserpine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SERPALAN?
- What are the global sales for SERPALAN?
- What is Average Wholesale Price for SERPALAN?
Summary for SERPALAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 101 |
| Patent Applications: | 1,211 |
| DailyMed Link: | SERPALAN at DailyMed |
US Patents and Regulatory Information for SERPALAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lannett | SERPALAN | reserpine | TABLET;ORAL | 010124-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lannett | SERPALAN | reserpine | TABLET;ORAL | 010124-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
